Download PDF
Z Gastroenterol 2017; 55(01): 56-62
DOI: 10.1055/s-0042-111048
Kasuistik
© Georg Thieme Verlag KG Stuttgart · New York

A liver nodule in a patient transplanted for primary sclerosing cholangitis: an interdisciplinary diagnostic approach

Eine unklare Leberraumforderung in der Transplantatleber einer Patientin mit primär sklerosierender Cholangitis: ein interdisziplinärer diagnostischer Ansatz
Sven Heiko Loosen
1   Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), University Hospital RWTH Aachen, Aachen, Germany
,
Maximilian Schmeding
2   Department of General, Visceral and Transplantation Surgery, University Hospital RWTH Aachen, Aachen, Germany
,
Christoph Roderburg
1   Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), University Hospital RWTH Aachen, Aachen, Germany
,
Marcel Binnebösel
2   Department of General, Visceral and Transplantation Surgery, University Hospital RWTH Aachen, Aachen, Germany
,
Ilknur Temizel
1   Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), University Hospital RWTH Aachen, Aachen, Germany
,
Felix M. Mottaghy
3   Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany
,
Jens J.W. Tischendorf
1   Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), University Hospital RWTH Aachen, Aachen, Germany
,
Frank Tacke
1   Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), University Hospital RWTH Aachen, Aachen, Germany
,
Nadine T. Gaisa
4   Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
,
Kais Hussein
5   Institute of Pathology, Hannover Medical School, Hannover, Germany
,
Ulrich Lehmann
5   Institute of Pathology, Hannover Medical School, Hannover, Germany
,
Christian Trautwein   *
1   Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), University Hospital RWTH Aachen, Aachen, Germany
,
Ulf Peter Neumann   *
2   Department of General, Visceral and Transplantation Surgery, University Hospital RWTH Aachen, Aachen, Germany
,
Tom Luedde   *
1   Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), University Hospital RWTH Aachen, Aachen, Germany
› Author Affiliations
Further Information

Publication History

24 April 2016

19 June 2016

Publication Date:
05 October 2016 (online)

Also available at
    Permissions and Reprints

Abstract

We report the case of a 53-year-old female patient who was transplanted with the liver of a 71-year-old male donor for advanced primary sclerosing cholangitis (PSC) and who additionally was diagnosed with a histologically non-classifiable colitis shortly before transplantation. Upon follow-up abdominal ultrasound 4 months after transplantation, a liver lesion measuring 16 × 23 mm was detected in the transplanted liver. This lesion had not been noticed immediately after transplantation and showed a pattern suspicious for malignancy in contrast-enhanced ultrasound. In line, a biopsy revealed the presence of a metastasis of an adenocarcinoma of colorectal origin, suggesting that a colitis- and PSC-associated colorectal cancer of the recipient might have been overseen upon the initial diagnostic workup. Despite two negative follow-up colonoscopies, this hypothesis was further supported by a strong positive signal in projection to the cecum in a subsequently performed PET/CT-scan. However, surgical resection of the right colon that was performed simultaneously with the atypical resection of the liver metastasis only revealed an inflamed diverticulum but no malignancy in the resected colon segment. Moreover, cytogenetic and molecular genetic testing on the resected specimens clearly attributed the metastasis to the male donor. On the one hand, this case underlines the necessity of endoscopic surveillance of patients with PSC and/or inflammatory bowel disease as well as the challenges in diagnosis of colitis-associated cancer. On the other hand, it shows that the acceptance of organs from elderly donors in times of organ shortage might be linked to an increased risk of donor transmitted malignancies.

Zusammenfassung

Wir berichten den Fall einer 53-jährigen Patientin, die aufgrund einer fortgeschrittenen primär sklerosierenden Cholangitis (PSC) sowie einer begleitenden histologisch nicht klassifizierbaren Kolitis mit der Leber eines 71-jährigen Spenders transplantiert wurde. Im Rahmen einer sonografischen Kontrolle 4 Monate nach Lebertransplantation fiel eine 16 × 23 mm große intrahepatische Raumforderung auf, die unmittelbar nach Transplantation nicht vorhanden war und sich in der Kontrastmittelsonografie als malignitätsverdächtig darstellte. Die Punktion ergab die Diagnose einer Metastase eines Adenokarzinoms vom kolorektalen Bautyp, sodass der dringende Verdacht auf ein Colitis ulcerosa- und PSC-assoziiertes kolorektales Karzinom (KRK) der Empfängerin mit Metastasierung in die Transplantatleber vorlag, welches in der initialen Diagnostik übersehen wurde. Dieser Verdacht erhärtete sich trotz 2 negativer Follow-up-Koloskopien durch eine PET-/CT-Untersuchung mit starker Tracer-Anreicherung im ileozökalen Übergang. Es wurde der interdisziplinäre Entschluss zur Lebermetastasenresektion sowie zusätzlich zur Resektion des entsprechenden Kolonbereichs gefasst, welcher allerdings den Befund eines entzündeten Divertikels als Korrelat des PET-/CT-Befunds erbrachte. Letztendlich konnte mittels zytogenetischer und molekulargenetischer Verfahren der einzelnen Resektate die Lebermetastase eindeutig dem männlichen Spender zugeordnet werden. Zum einen unterstreicht dieser Fall die Notwendigkeit und die Besonderheiten der endoskopischen Überwachung und KRK-Diagnostik bei Patienten mit PSC und/oder chronisch entzündlichen Darmerkrankungen. Zum anderen zeigt dieser Fall, dass in Zeiten der Organknappheit und der damit verbundenen zunehmenden Verwendung von Organen älterer Spender die Möglichkeit einer Transmission unerkannter maligner Erkrankungen an den Empfänger zu bedenken ist.

Schlüsselwörter

Kontrastmittelsonografie - Lebertransplantation - erweiterter Organspenderkreis - primär sklerosierende Cholangitis (PSC) - Colitis ulcerosa (CU) - FISH-Analyse

Key words

contrast-enhanced ultrasound - liver transplantation - marginal donors - primary sclerosing cholangitis (PSC) - ulcerative colitis (UC) - FISH

* These authors contributed equally to this work.


 

  • References

  • 1 Farrant JM. Hayllar KM. Wilkinson ML. et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710-1717
    CrossrefPubMedGoogle Scholar
  • 2 Hirschfield GM. Karlsen TH. Lindor KD. et al. Primary sclerosing cholangitis. Lancet 2013; 382: 1587-1599
    CrossrefPubMedGoogle Scholar
  • 3 Lindkvist B. Benito de Valle M. Gullberg B. et al. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology 2010; 52: 571-577
    CrossrefPubMedGoogle Scholar
  • 4 Molodecky NA. Kareemi H. Parab R. et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology 2011; 53: 1590-1599
    CrossrefPubMedGoogle Scholar
  • 5 Saich R. Chapman R. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol 2008; 14: 331-337
    CrossrefPubMedGoogle Scholar
  • 6 Talwalkar JA. Lindor KD. Primary sclerosing cholangitis. Inflamm Bowel Dis 2005; 11: 62-72
    CrossrefPubMedGoogle Scholar
  • 7 Ali AH. Carey EJ. Lindor KD. Current research on the treatment of primary sclerosing cholangitis. Intractable Rare Dis Res 2015; 4: 1-6
    CrossrefPubMedGoogle Scholar
  • 8 Broome U. Olsson R. Loof L. et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610-615
    CrossrefPubMedGoogle Scholar
  • 9 Ponsioen CY. Vrouenraets SME. Prawirodirdjo W. et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 2002; 51: 562-566
    CrossrefPubMedGoogle Scholar
  • 10 Razumilava N. Gores GJ. Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 2011; 54: 1842-1852
    CrossrefPubMedGoogle Scholar
  • 11 Burak K. Angulo P. Pasha TM. et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004; 99: 523-526
    CrossrefPubMedGoogle Scholar
  • 12 Bonato G. Cristoferi L. Strazzabosco M. et al. Malignancies in primary sclerosing cholangitis – a continuing threat. Dig Dis 2015; 33 (Suppl. 02) 140-148
    CrossrefPubMedGoogle Scholar
  • 13 Soetikno RM. Lin OS. Heidenreich PA. et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002; 56: 48-54
    CrossrefPubMedGoogle Scholar
  • 14 Bergquist A. Ekbom A. Olsson R. et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002; 36: 321-327
    CrossrefPubMedGoogle Scholar
  • 15 Rossi RE. Conte D. Massironi S. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update. Eur J Gastroenterol Hepatol 2015; 28: 123-131
    PubMedGoogle Scholar
  • 16 Singh S. Khanna S. Pardi DS. et al. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 2013; 19: 1631-1638
    CrossrefPubMedGoogle Scholar
  • 17 Tung BY. Emond MJ. Haggitt RC. et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001; 134: 89-95
    CrossrefPubMedGoogle Scholar
  • 18 Triantos CK. Koukias NM. Nikolopoulou VN. et al. Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther 2011; 34: 901-910
    CrossrefPubMedGoogle Scholar
  • 19 Lindor KD. Kowdley KV. Luketic VAC. et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009; 50: 808-814
    CrossrefPubMedGoogle Scholar
  • 20 Imam MH. Sinakos E. Gossard AA. et al. High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis. Aliment Pharmacol Ther 2011; 34: 1185-1192
    CrossrefPubMedGoogle Scholar
  • 21 Eaton JE. Silveira MG. Pardi DS. et al. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol 2011; 106: 1638-1645
    CrossrefPubMedGoogle Scholar
  • 22 Torres J. Pineton de Chambrun G. Itzkowitz S. et al. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Aliment Pharmacol Ther 2011; 34: 497-508
    CrossrefPubMedGoogle Scholar
  • 23 Wiesner RH. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Best Pract Res Clin Gastroenterol 2001; 15: 667-680
    CrossrefPubMedGoogle Scholar
  • 24 Schöning W. Schmeding M. Ulmer F. et al. Liver transplantation for patients with cholestatic liver diseases. Viszeralmedizin 2015; 31: 194-198
    CrossrefPubMedGoogle Scholar
  • 25 Goldberg D. French B. Thomasson A. et al. Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era. Liver Transpl 2011; 17: 1355-1363
    CrossrefPubMedGoogle Scholar
  • 26 EASL. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol 2016; 64: 433-485
    CrossrefPubMedGoogle Scholar
  • 27 Eurotransplant. Chapter 5 – ET Liver Allocation System (ELAS). Eurotransplant Man 2015.
    PubMedGoogle Scholar
  • 28 Claessen MMH. Lutgens MWMD. van Buuren HR. et al. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Inflamm Bowel Dis 2009; 15: 1331-1336
    CrossrefPubMedGoogle Scholar
  • 29 Loftus EV. Harewood GC. Loftus CG. et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005; 54: 91-96
    CrossrefPubMedGoogle Scholar
  • 30 Lundqvist K. Broomé U. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum 1997; 40: 451-456
    CrossrefPubMedGoogle Scholar
  • 31 Boberg KM. Chapman RW. Chazouille O. et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237-267
    CrossrefPubMedGoogle Scholar
  • 32 Dignass A. Preiss JC. Aust DE. et al. Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011. Z Gastroenterol 2011; 49: 1276-1341
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Broomé U. Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006; 26: 31-41
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Marion JF. Waye JD. Present DH. et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008; 103: 2342-2349
    CrossrefPubMedGoogle Scholar
  • 35 Rutter MD. Saunders BP. Schofield G. et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004; 53: 256-260
    CrossrefPubMedGoogle Scholar
  • 36 Kiesslich R. Fritsch J. Holtmann M. et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-888
    CrossrefPubMedGoogle Scholar
  • 37 Dekker E. van den Broek FJ. Reitsma JB. et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007; 39: 216-221
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Dvorchik I. Subotin M. Demetris AJ. et al. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology 2002; 35: 380-384
    CrossrefPubMedGoogle Scholar
  • 39 Hanouneh IA. Macaron C. Lopez R. et al. Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis. Inflamm Bowel Dis 2012; 18: 269-274
    CrossrefPubMedGoogle Scholar
  • 40 Vera A. Gunson BK. Ussatoff V. et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003; 75: 1983-1938
    CrossrefPubMedGoogle Scholar
  • 41 Loftus EV. Aguilar HI. Sandborn WJ. et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998; 27: 685-690
    CrossrefPubMedGoogle Scholar
  • 42 Nguyen GC. Frick KD. Dassopoulos T. Medical decision analysis for the management of unifocal, flat, low-grade dysplasia in ulcerative colitis. Gastrointest Endosc 2009; 69: 1299-1310
    CrossrefPubMedGoogle Scholar
  • 43 Pekow JR. Hetzel JT. Rothe JA. et al. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis 2010; 16: 1352-1356
    CrossrefPubMedGoogle Scholar
  • 44 Post AB. Bozdech JM. Lavery I. et al. Colectomy in patients with inflammatory bowel disease and primary sclerosing cholangitis. Dis Colon Rectum 1994; 37: 175-178
    CrossrefPubMedGoogle Scholar
  • 45 Csikesz NG. Nguyen LN. Tseng JF. et al. Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg 2009; 208: 96-103
    CrossrefPubMedGoogle Scholar
  • 46 Ståhlberg D. Veress B. Tribukait B. et al. Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study. Dis Colon Rectum 2003; 46: 770-778
    CrossrefPubMedGoogle Scholar
  • 47 Eurotransplant. Chapter 3 – Allocation General. Eurotransplant Man 2014.
    PubMedGoogle Scholar
  • 48 Eurotransplant. Annual Report 2014.
    PubMedGoogle Scholar
  • 49 Eurotransplant. Statistics Report Library – Report 1103P_2015.
    PubMedGoogle Scholar
  • 50 Bacchella T. Galvão FHF. Jesus de Almeida JL. et al. Marginal grafts increase early mortality in liver transplantation. Sao Paulo Med J 2008; 126: 161-165
    CrossrefPubMedGoogle Scholar
  • 51 Attia M. Silva MA. Mirza DF. The marginal liver donor--an update. Transpl Int 2008; 21: 713-724
    CrossrefPubMedGoogle Scholar
  • 52 Avolio AW. Nardo B. Agnes S. et al. The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. Transplant Proc 2005; 37: 2584-2586
    CrossrefPubMedGoogle Scholar
  • 53 Pomfret EA. Sung RS. Allan J. et al. Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons’ State-of-the-Art Winter Symposium. Am J Transplant 2008; 8: 745-752
    CrossrefPubMedGoogle Scholar
  • 54 Friend PJ. Imber CJ. Current status of liver transplantation. Methods Mol Biol 2006; 333: 29-46
    PubMedGoogle Scholar
  • 55 Jiménez-Romero C. Caso Maestro O. Cambra Molero F. et al. Using old liver grafts for liver transplantation: where are the limits?. World J Gastroenterol 2014; 20: 10691-10702
    CrossrefPubMedGoogle Scholar
  • 56 Goldberg D. Bittermann T. Makar G. Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis. Am J Transplant 2012; 12: 1603-1609
    CrossrefPubMedGoogle Scholar
  • 57 Desai R. Neuberger J. Donor transmitted and de novo cancer after liver transplantation. World J Gastroenterol 2014; 20: 6170-6179
    CrossrefPubMedGoogle Scholar
  • 58 Desai R. Collett D. Watson CJ. et al. Cancer transmission from organ donors-unavoidable but low risk. Transplantation 2012; 94: 1200-1207
    CrossrefPubMedGoogle Scholar
  • 59 Hassanain M. Novel guidelines for organ donor cancer screening. Ann Transplant 2014; 19: 241-247
    CrossrefPubMedGoogle Scholar
  • 60 Eurotransplant. Chapter 9 – The Donor. Eurotransplant Man 2015.
    PubMedGoogle Scholar